Telemus Capital, LLC Exact Sciences Corp Transaction History

Telemus Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$72.92 - $102.01 $210,884 - $295,012	-2,892 Closed	0 $0
Q2 2020 Jul 17, 2020	SELL	$55.75 - $92.75 $16,725 - $27,825	-300 Reduced 9.4%	2,892 $266,000
Q1 2020 Jun 05, 2020	BUY	$37.9 - $104.44 $8,034 - $22,141	212 Added 7.11%	3,192 $274,000
Q4 2019 Jan 24, 2020	BUY	$77.66 - $99.74 $231,426 - $297,225	2,980 New	2,980 $276,000

699

160M

5.84M

2.58M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.48B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Telemus Capital, LLC with notifications on news.